Quantum BioPharma Ltd. Class Action Lawsuit Filing

Quantum BioPharma Ltd. ("Quantum BioPharma") has announced that a class action lawsuit has been filed by a shareholder, Paul Durkacz, alleging stock manipulation by CIBC and RBC between January 6, 2021, and October 15, 2025. The company intends to seek appointment as lead plaintiff to protect its shareholders' interests. Quantum BioPharma is a biopharmaceutical company focused on neurodegenerative and metabolic disorders, with its lead compound Lucid-MS targeting multiple sclerosis. The company has also spun out its unbuzzd™ product into Unbuzzd Wellness Inc., retaining a significant ownership stake and royalty rights. Quantum BioPharma is involved in litigation and is pursuing whistleblower submissions related to alleged market manipulation.